What development phase is Dihydroergocristin in?

Dihydroergocristin is FDA-approved (marketed).

What are the side effects of Dihydroergocristin?

Common side effects include Nausea, Gastric disturbances.

What is the generic name of Dihydroergocristin?

dihydroergocristine is the generic (nonproprietary) name of Dihydroergocristin.

Last reviewed 2026-04-20 · How we verify

Dihydroergocristin (dihydroergocristine)

FDA-approved active Quality 10/100

At a glance

Generic name	dihydroergocristine
Drug class	dihydroergocristine
Target	5-hydroxytryptamine receptor 6, Cytochrome P450 2C19, Cytochrome P450 2C9
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

Nausea
Gastric disturbances

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dihydroergocristin CI brief — competitive landscape report
Dihydroergocristin updates RSS · CI watch RSS
portfolio CI